NCT01741454View on ClinicalTrials.gov

Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction

PHASE4CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions
Ureteral Obstruction
Interventions
DRUG

Tamsulosin

0.4 mg by mouth once per day.

DRUG

Tolterodine ER

4 mg by mouth once a day.

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01741454 - Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction | Biotech Hunter | Biotech Hunter